Skip to main content
. 2013 Oct 30;13:510. doi: 10.1186/1471-2407-13-510

Table 3.

SNPs selected for analysis

NCBI SNP Reference Cytogenetic Band Gene a Reference
rs17468277
2q33.1
ALS2CR12 (synonymous) (CASP8)b
[35]
rs13387042
2q35
intergenic
[32,33]
rs889312
5q11.2
MAP3K1 (upstream)
[8,33]
rs10941679
5p12
intergenic
[8,34]
rs2736098
5p15.33
TERT (synonymous)
[31]
rs13281615
8q24.21
intergenic
[8,33]
rs3731249
9p21.3
CDKN2A (missense; A148T)
[37], CO-Ic
rs1219648
10q26
FGFR2 (intron)
[30]
rs2981582
10q26
FGFR2 (intron)
[8,33]
rs3817198
11p15.5
LSP1 (intron)
[8]
rs766173
13q13.1
BRCA2 (missense; N289H)
CO-I
rs1799944
13q13.1
BRCA2 (missense; N991D)
[36], CO-I
rs28897710
13q13.1
BRCA2 (missense; T598A)
CO-I
rs3803662
16q12.1
TOX3/LOC643714 (between)
[8,32,33]
rs243865
16q13-q21
MMP2 (promoter)
[29]
rs152451 16p12.2 PALB2 (missense; Q559R) CO-I

a/NCBI ID of genes localized in proximity to the SNPs of interest (source: HapMap).

b/SNP rs17468277 is in strong LD (r2 = 1) with rs1045485 in CASP8 (D302H).

c/SNP selected based on the date provided by Genetic Counseling of Cancer Center and Institute of Oncology (CO-I) in Warsaw.